PPARG and endometrial cancer: Most importantly, copy number variations and nucleotide mutations in the exon regions of PPARs differentially influenced endometrial cancer prognosis and overall survival, while a PPARγ/estrogen-related receptor-α ratio ≤1.86 constituted an independent risk factor for endometrial carcinogenesis.